MedPath

Uterine Preservation in the Management of Placenta Accreta Spectrum Disorders

Not Applicable
Not yet recruiting
Conditions
Placenta Accreta Spectrum
Interventions
Other: Conservative/Expectant Management
Registration Number
NCT06512181
Lead Sponsor
University of Pennsylvania
Brief Summary

This study for the conservative management of placenta accreta spectrum disorders (PAS), which are a major cause of maternal morbidity and mortality. The most common management strategy for PAS in the United States is a preterm cesarean-hysterectomy. However, accumulating data show that conservative management is safer and is preferred by some patients. In selected participants (n=15) who desire uterine preservation, the investigators provide the option of conservative management, which will be defined as leaving the placenta in the uterus after delivery of the infant. This is a single-arm single-site pilot study where all participants will be carefully monitored during a standard postpartum inpatient stay and with outpatient follow-up until the uterus is empty.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
15
Inclusion Criteria
  1. Provision of signed and dated informed consent form.
  2. Stated willingness to comply with all study procedures and availability for the duration of the study.
  3. A person with a uterus, age 18 or older
  4. Currently 16-36 weeks pregnant with an intrauterine gestation
  5. History of cesarean delivery AND placenta previa OR anterior low-lying placenta AND suspected of having PAS on prenatal imaging (ultrasound/MRI)
  6. Patients for whom the usual management would be cesarean-hysterectomy.
  7. Patient desires uterine preservation
  8. Agreement to adhere to Lifestyle Considerations (see section 5.3) throughout study duration.
Read More
Exclusion Criteria

• Have a low antenatal suspicion for PAS based on imaging.

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Uterine preservationConservative/Expectant ManagementConservative management of PAS with the inclusion of antibiotics and uterine artery embolization, followed by close monitoring.
Primary Outcome Measures
NameTimeMethod
Hysterectomy rateDelivery through 1 year

Percent of participants who undergo a hysterectomy

Secondary Outcome Measures
NameTimeMethod
Endometritis rateDelivery through 1 year

Percent of participants who have endometritis

Frequency of vaginal bleedingDelivery through 1 year

Percent of participants with vaginal bleeding at each time point

Frequency of pelvic painDelivery through 1 year

Percent of participants with pelvic pain at each time point

Coagulopathy rateDelivery through 1 year

Percent of participants who have coagulopathy

Trial Locations

Locations (1)

Hospital of the University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath